title: Expression of the hepatitis C virus structural proteins in mammalian cells induces morphology similar to that in natural infection.
abstract: Like many positive-strand RNA viruses, replication of the hepatitis C virus (HCV) is associated with cytoplasmic membrane rearrangements. However, it is unclear which HCV proteins induce these ultrastructural features. This work examined the morphological changes induced by expression of the HCV structural proteins, core, E1 and E2, expressed from a Semliki Forest Virus (SFV) recombinant RNA replicon. Electron microscopy of cells expressing these proteins showed cytoplasmic vacuoles containing membranous and electron-dense material that were distinct from the type I cytoplasmic vacuoles induced during SFV replicon replication. Immunogold labelling showed that the core and E2 proteins localized to the external and internal membranes of these vacuoles, but at times were also associated with some of the internal amorphous material. Dual immunogold labelling with antibodies raised against the core protein and against an endoplasmic reticulum (ER)-resident protein (protein disulphide isomerase) showed that the HCV-induced vacuoles were associated with ER-labelled membranes. This report has identified an association between the HCV core and E2 proteins with induced cytoplasmic vacuoles which are morphologically similar to those observed in HCV-infected liver tissue, suggesting that the HCV structural proteins may be responsible for the induction of these vacuoles during HCV replication in vivo.
authors.affiliation: Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Herston, Brisbane, Australia.
authors.forename: S J
authors.initials: SJ
authors.lastname: Greive
authors.forename: R I
authors.initials: RI
authors.lastname: Webb
authors.forename: J M
authors.initials: JM
authors.lastname: Mackenzie
authors.forename: E J
authors.initials: EJ
authors.lastname: Gowans
mesh_terms: D000818:Animals; D002460:Cell Line; D002462:Cell Membrane / Q000473:pathology; D006224:Cricetinae; D003588:Cytopathogenic Effect, Viral; D015870:Gene Expression; D016174:Hepacivirus / Q000235:genetics / Q000378:metabolism; D006526:Hepatitis C / Q000473:pathology*; D018937:Hepatitis C Antibodies / Q000276:immunology; D007150:Immunohistochemistry; D008322:Mammals; D019704:Protein Disulfide-Isomerases / Q000032:analysis / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis / Q000235:genetics; D014758:Viral Core Proteins / Q000096:biosynthesis* / Q000235:genetics; D014759:Viral Envelope Proteins / Q000096:biosynthesis* / Q000235:genetics
chemical_list: C087035:E1 protein, Hepatitis C virus; D018937:Hepatitis C Antibodies; D011993:Recombinant Fusion Proteins; D014758:Viral Core Proteins; D014759:Viral Envelope Proteins; C069130:nucleocapsid protein, Hepatitis C virus; C091015:glycoprotein E2, Hepatitis C virus; D019704:Protein Disulfide-Isomerases